The production of Neolyse Ibbenbüren GmbH, a joint venture of AkzoNobel Specialty Chemicals and Evonik Industries AG at the AkzoNobel site in Ibbenbüren (Germany), is off to a successful start.
The plant with its state-of-the-art membrane technology has an annual capacity of 120,000 metric tons of potassium hydroxide solution and 75,000 metric tons of chlorine and hydrogen.
Operated by AkzoNobel, the facility strengthens the respective leading positions of both companies.
AkzoNobel commercializes chlorine and hydrogen, while Evonik distributes the locally produced potassium hydroxide solution and processes parts of it into other products such as potassium carbonate, potassium bicarbonate and potassium formate at its Lülsdorf site.
“The Ibbenbüren facility sets a completely new standard for the chlor-alkali industry,” said Werner Fuhrmann, Chairman of the AkzoNobel Specialty Chemicals Executive Board, during the official opening ceremony of the new facility. “It enables us to secure the supply of our customers in the long term while further improving our company’s sustainability profile and operational efficiency.”
The new production process at the site improves the ecological footprint of every metric ton of chlorine produced in Ibbenbüren by 25 to 30 percent, resulting in lower energy consumption and fewer CO2 emissions. “We demonstrated throughout the course of the project that two experienced partners can contribute their diverse experience to intelligently shape their business environment. We complement each other very well and look forward to continuing our collaboration, which benefits our customers and therefore ultimately also the market for potassium hydroxide,” noted Dr. Harald Schwager, Deputy Chairman of the Evonik Executive Board, on the occasion of opening the plant.
AkzoNobel Specialty Chemicals is the market leader for industrial salt, chlorine and chloromethanes in Europe.
Evonik is the European market leader for potassium hydroxide solution and potassium derivatives as well as a leading global provider of alcoholates with a production site in Lülsdorf (Germany).
Images: : Ibbenbüren plant
The new membrane electrolysis plant in Ibbenbueren was completed in one and a half years.
Source: AkzoNobel Specialty Chemicals
Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-orientated innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evonik’s corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world with more than 35,000 employees. In fiscal 2016, the enterprise generated sales of around €12.7 billion and an operating profit (adjusted EBITDA) of about €2.165 billion.
About Performance Materials
The Performance Materials Segment is managed by Evonik Performance Materials GmbH. The segment focuses its global activities on developing and manufacturing polymer materials and intermediates, especially for use in agriculture and in the rubber and plastics industry. In 2016, the segment’s roughly 4,400 employees generated sales about €3.2 billion.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.